Publications by authors named "Ya-Ke Yao"
Tislelizumab-related enteritis successfully treated with adalimumab: A case report.
World J Clin Cases
October 2022
Article Synopsis
- PD-1 inhibitors like tislelizumab are becoming standard treatment for lung cancer but can cause adverse reactions like enteritis.
- A case was reported where a lung cancer patient experienced enteritis after treatment with tislelizumab and was successfully treated with adalimumab.
- Adalimumab appears to be a viable alternative for treating PD-1 related enteritis in patients who don't respond to glucocorticoids.
MicroRNA (miRNA)-based targeting in cancer has emerged as a potential therapeutic strategy. miR-206 has recently been implicated in cancer. However, the role and molecular mechanism of miR-206 in lung adenocarcinoma are still unclear.
View Article and Find Full Text PDF